Updates
- FDA · RecallFDA class II recall for specific amlodipine/olmesartan tablets
- CDC · Food safetyCertain frozen sashimi recalled for undeclared wheat, soy, and sesame
- FDA · RecallFDA classifies a recall for cyproheptadine syrup with crystallization
- CDC · Food safetyYusol International Foods expands recall of OLA-OLA POUNDED YAM
- FDA · RecallNaropin vials recalled for hair contamination
- CDC · Food safetyRecall of frozen vegan coconut fudge sandwiches over undeclared egg
- CDC · Food safetyRecall of glutinous rice balls with undeclared peanuts
- FDA-SAFETYThoracic stent graft recall for Relay Pro system
- FDA-SAFETYCorrection for convenience kits containing recalled lidocaine, bupivacaine and saline
- FDA-SAFETYEarly alert for possible catheter tip separation with ENROUTE system
- MHRA · SafetyACE inhibitors: warning about delayed angioedema types
- CDC · GuidanceCDC updates dengue risk areas for travel planning
- FDA-SAFETYAdequan injections recalled due to visible glass fiber
- FDA-SAFETYBD recalls specific needle set lots due to obturator removal difficulty
- CDC · GuidanceCDC clinical overview of measles
- MHRA · SafetySmall GBS risk after Abrysvo or Arexvy RSV vaccination
- CDC · GuidanceCDC fellowships and training opportunities
- MHRA · SafetyMHRA updates valproate safety and education materials
- FDA · AnnouncementFirst freeze-dried plasma product licensed in the U.S.
- FDA · ApprovalFDA approves dapagliflozin and metformin extended-release tablets
- FDA · ApprovalFDA approval of sitagliptin tablets for type 2 diabetes
- FDA · ApprovalFDA approval of MEKTOVI for certain cancers
- WHO · NewsWHO and Netherlands renew climate and health partnership
- FDA · AnnouncementFDA clears first OTC continuous glucose monitor for children